Long‐Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome

BACKGROUND. Patients with neuroendocrine tumors (NETs) and carcinoid syndrome experience considerable morbidity and mortality; carcinoid syndrome may be associated with shorter survival. Carcinoid syndrome is linked to tumoral secretion of serotonin and other bioactive substances. The subsequent deb...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Anthony, Lowell B., Kulke, Matthew H., Caplin, Martyn E., Bergsland, Emily, Öberg, Kjell, Pavel, Marianne, Hörsch, Dieter, Warner, Richard R.P., O'Dorisio, Thomas M., Dillon, Joseph S., Lapuerta, Pablo, Kassler‐Taub, Kenneth, Jiang, Wenjun
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Endocrinology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6693702/
https://ncbi.nlm.nih.gov/pubmed/30651397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0236
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados